SageView Advisory Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
SageView Advisory Group's WST Position: Q3 2026 in Review
SageView Advisory Group opened a new position in West Pharmaceutical (WST) in Q3 2026: 579 shares worth $215K. The stake represents 0.01% of the portfolio and ranks #566 among its holdings. This is a return to the name: SageView Advisory Group previously reported a position in WST as recently as Q4 2025.
SageView Advisory Group first reported a position in WST in Q1 2024 and has held it in 3 quarters since. The position peaked at $332K in Q1 2024. 878 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- SageView Advisory Group held 579 shares of West Pharmaceutical worth $215K as of Q3 2026.
- West Pharmaceutical was a new SageView Advisory Group position in Q3 2026.
- West Pharmaceutical made up 0.01% of SageView Advisory Group's portfolio in Q3 2026, its #566 holding.
- SageView Advisory Group first reported a position in West Pharmaceutical in Q1 2024 and has held it in 3 quarters since.
- SageView Advisory Group's West Pharmaceutical position peaked at $332K in Q1 2024.
- 878 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on SageView Advisory Group's 13F filing for Q3 2026, filed 16 Nov 2026.